Overview
Rx Redefined gives doctors a compliant platform to manage DMEPOS distribution directly to patients. It offers Full Service to help practices become licensed DMEPOS suppliers and meet the 30 standards, and In Office to ship supplies straight from the clinic, with integration to distribution centers and multiple brands. The company differentiates itself by physician-managed, compliant delivery for chronic patients, aiming to reduce product switching, shorten delivery times, and using add-on services like revenue cycle management and audits, with evidence of a 23% drop in utilization for some urological prosthetics. Its goal is to streamline the healthcare supply chain, improve patient outcomes, and grow through partnerships and funding.
Work here?Claim your company
Simplify's take
What believers are saying
- Rx Redefined updated its site in August 2026, signaling active product expansion and sales motion.
- Revelio Labs reported 141 employees in March 2026, up 128% from 2023.
- Indeed listed multiple open roles in 2026, including growth, clinical, and technical positions.
What critics are saying
- CMS DMEPOS supplier standards create audit risk; one compliance failure can freeze revenue quickly.
- Physician adoption depends on training and workflow changes; clinics abandon cumbersome distribution programs fast.
- McKesson, Cardinal Health, and Apria can undercut pricing, crushing margins and blocking scale.
What makes Rx Redefined unique
- Rx Redefined owns physician-led DMEPOS workflows, from licensing through billing and audits.
- Its August 2026 website shows 10+ distribution centers and two distinct physician products.
- The model reduces product switching for chronic patients by keeping prescribed brands and delivery paths.
Help us improve and share your feedback! Did you find this helpful?